Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs

Neuroscience Letters

Volumn 460, Issue 2, 2009, Pages 148-151

  Yavropoulou, Maria P ^a   Kotsa, Kalliopi ^a   Anastasiou, Olympia ^a   O'Dorisio, Thomas M ^b   Pappas, Theodore N ^c   Yovos, John G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

GIP secretion; Intracerebroventricular infusion of insulin; Neural regulation

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INCRETIN; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HORMONE RELEASE; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN INFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; VENOUS BLOOD;

ANIMALS; BLOOD GLUCOSE; DOGS; DRUG ADMINISTRATION ROUTES; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION; GLUCOSE; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENTRICULAR; INSULIN; SWEETENING AGENTS; TIME FACTORS;

EID: 67349276661     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.05.052     Document Type: Article

References (23)

1. Ahren B., and Holst J.J. The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50 (2001) 1030-1038
2. Ahren B., and Lundquist I. Effects of selective and nonselective b-adrenergic agents on insulin secretion in vivo. Eur. J. Pharmacol. 71 (1981) 93-104
3. Althage M.C., Ford E.L., Wang S., Tso P., Polonsky K.S., and Wice B.M. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J. Biol. Chem. 283 (2008) 18365-18376
4. Bishop E.A., Polak J.M., Green I.C., Bryant M.G., and Bloom S.R. The location of VIP in the pancreas of man and rat. Diabetologia 18 (1980) 73-78
5. Bryer-Ash M., Cheung A., and Pederson R.A. Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats. Regul. Pept. 5 (1994) 101-109
6. Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regul. Pept. 128 (2005) 117-124
7. Fridolf T., Sundler F., and Ahren B. Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res. 269 (1992) 275-279
8. Knuhtsen S., Holst J.J., Baldissera F.G., Skak-Nielsen T., Poulsen S.S., Jensen S.L., and Nielsen O.V. Gastrin releasing peptide in the porcine pancreas. Gastroenterology 92 (1978) 1153-1158
9. Kogire M., Izukura M., Gomez G., Uchida T., Greeley Jr. G.H., and Thompson J.C. Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs. Dig. Dis. Sci. 35 (1990) 453-457
10. Manin M., Broer Y., Balage M., Rostene W., and Grizard J. Metabolic clearance of insulin from the cerebrospinal fluid in the anesthetized rat. Peptides 11 (1990) 5-12
11. Obici S., Zhang B.B., Karkanias G., and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8 (2002) 1376-1382
12. Pocai A., Lam T.K., Gutierrez-Juarez R., Obici S., Schwartz G.J., Bryan J., Aguilar-Bryan L., and Rossetti L. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434 (2005) 1026-1031
13. Rafaelsen O.J. Insulin action on the central nervous system. Acta Med. Scand. Suppl. 476 (1967) 75-78
14. Salera M., Ebert R., Giacomoni P., Pironi L., Venturi S., and Corinaldesi R. Adrenergic modulation of gastric inhibitory polypeptide secretion in man. Dig. Dis. Sci. 27 (1982) 794-800
15. Sipols A.J., Baskin D.G., and Schwartz M.W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44 (1995) 147-151
16. 2+ efflux and insulin secretion from isolated rat islets. Acta Physiol. Scand. 132 (1988) 289-296
17. Taborsky G.J., and Bergman R.N. Effect of insulin, glucose, and 2-deoxy-glucose infusion into the third cerebral ventricle of conscious dogs on plasma insulin, glucose, and free fatty acids. Diabetes 29 (1980) 278-283
18. Wallum B.J., Taborsky Jr. G.J., Porte Jr. D.J., Figlewicz D.P., Jacobson L., Beard J.C., Ward W.K., and Dorsa D. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J. Clin. Endocrinol. Metab. 64 (1987) 190-194
19. Woods S.C., Lotter E.C., McKay L.D., and Porte Jr. D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282 (1979) 503-505
20. Woods S.C., and Porte Jr. D. Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am. J. Physiol. 233 (1977) E331-E334
21. Yavropoulou M.P., Kotsa K., Kesisoglou I., Anastasiou O.E., and Yovos J.G. Intracerebroventricular infusion of neuropeptide Y increases glucose dependent-insulinotropic peptide secretion in the fasting conscious dog. Peptides 29 (2008) 2281-2285
22. Yin W., Tibbs R., Aoki K., Badr A., and Zhang J. Metabolic alterations in cerebrospinal fluid from double hemorrhage model of dogs. Neurol. Res. 23 (2001) 87-96
23. Yovos J.G., O'Dorisio T.M., Gaginella T.S., Cataland S., and Carey L.C. Development and validation of an in vivo brain-gut peptide model. Regul. Pept. Suppl. (1983) 222